Enhanced COPD Management in Suspected Lung Cancer Patients
Summary
A new open-label randomized controlled trial (NCT07543601) evaluating tailored COPD consultations has been registered on ClinicalTrials.gov. The study will enroll patients under evaluation for lung cancer at Lillebaelt Hospital Vejle, Denmark. The trial aims to assess whether early diagnosis and optimal COPD treatment can improve clinical outcomes, reduce healthcare costs, and potentially increase survival rates for patients with both conditions.
“Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
A new clinical trial record for NCT07543601 has been registered on ClinicalTrials.gov, describing an open-label randomized controlled trial at Lillebaelt Hospital Vejle investigating the impact of tailored COPD consultations on patients being evaluated for lung cancer. The study will assess early COPD diagnosis and optimal treatment on health status, healthcare costs, and survival outcomes. No regulatory obligations are created by this registry entry.
Healthcare providers and clinical investigators involved in lung cancer screening or respiratory care may wish to note the study's findings upon completion, as positive results could support integrated COPD-lung cancer care pathways. This registry entry does not impose compliance requirements and requires no action from regulated entities.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Enhanced COPD Management in Suspected Lung Cancer Patients
N/A NCT07543601 Kind: NA Apr 22, 2026
Abstract
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.
This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle.
The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Conditions: COPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis), Lung Neoplasm Malignant, Lung Carcinoma, Pulmonary Neoplasms, Pulmonary Neoplasm, Pulmonary Cancers, Pulmonary Cancer, Pulmonary Carcinoma, COPD, COPD - Chronic Obstructive Pulmonary Disease, Airflow Obstruction, Chronic
Interventions: Tailored COPD consultations
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.